Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports.

Authors:
Address: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong Da-Street, Fengtai District, Beijing 100071, People's Republic of China.
Journal:

Publication:

abstract

BACKGROUND:

Japanese encephalitis (JE) vaccination is the most effective measure for preventing JE disease. The live attenuated JE vaccine, which has shown good efficacy and safety, has been widely used in China.

case PRESENTATIONS:

We report four laboratory-confirmed JE cases detected in JE-endemic areas during the JE virus (JEV) transmission season, who all received a first dose of live attenuated JE vaccine within 2 weeks prior to the onset of illness. All cases presented with acute encephalitis and rapidly reduced consciousness. All cerebrospinal fluid (CSF) samples from the patients were positive for JEV-specific immunoglobulin M (IgM) antibodies, but viral isolation and polymerase chain reaction (PCR) detection of JEV were both negative.

CONCLUSIONS:

It is difficult to identify a causal link between the disease and the vaccination, as the source of positive CSF JEV IgM antibodies might be natural JEV infection or possibly due to a traumatic lumbar puncture. Our observations highlight the need for public health officers and doctors to consider reasonable vaccination policies during the JE season. In addition, continued surveillance as well as thorough investigation of any events that occur after JE vaccination is necessary.

Related Articles
Review Allergic reactions to Japanese encephalitis vaccine.
Immunol Allergy Clin North Am....
Review Allergic reactions to Japanese encephalitis vaccine.
Plesner AM. Immunol Allergy Clin North Am. 2003 Nov; 23(4):665-97.
[A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhonghua Liu Xing Bing Xue Za ...
[A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B, Jia L, Xu X. Zhonghua Liu Xing Bing Xue Za Zhi. 1999 Feb; 20(1):38-41.
An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
Am J Trop Med Hyg. 1999
An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B, Nisalak A, Gettayacamin M, Thirawuth V, Young GD, Myint KS, Ferguson LM, Hoke CH Jr, Innis BL, Vaughn DW. Am J Trop Med Hyg. 1999 Mar; 60(3):329-37.
Detection of Japanese encephalitis (JE) virus-specific IgM in cerebrospinal fluid and serum samples from JE patients.
Jpn J Infect Dis. 2005
Detection of Japanese encephalitis (JE) virus-specific IgM in cerebrospinal fluid and serum samples from JE patients.
Chanama S, Sukprasert W, Sa-ngasang A, A-nuegoonpipat A, Sangkitporn S, Kurane I, Anantapreecha S. Jpn J Infect Dis. 2005 Oct; 58(5):294-6.
Review Overview: Japanese encephalitis.
Prog Neurobiol. 2010
Review Overview: Japanese encephalitis.
Misra UK, Kalita J. Prog Neurobiol. 2010 Jun; 91(2):108-20. Epub 2010 Feb 2.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.